| Literature DB >> 28031021 |
Mariëlle W van Ooijen1,2, Melvyn Roerdink3, Marga Trekop4, Thomas W J Janssen3,5, Peter J Beek3.
Abstract
BACKGROUND: The ability to adjust walking to environmental context is often reduced in older adults and, partly as result of this, falls are common in this population. A treadmill with visual context projected on its belt (e.g., obstacles and targets) allows for practicing step adjustments relative to that context, while concurrently exploiting the great amount of walking practice associated with conventional treadmill training. The present study was conducted to compare the efficacy of adaptability treadmill training, conventional treadmill training and usual physical therapy in improving walking ability and reducing fear of falling and fall incidence in older adults during rehabilitation from a fall-related hip fracture.Entities:
Keywords: Exercise; Falls; Hip fracture; Intervention studies; Older adults; Treadmill; Walking adaptability
Mesh:
Year: 2016 PMID: 28031021 PMCID: PMC5198499 DOI: 10.1186/s12877-016-0388-x
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Fig. 1Adaptability treadmill training. The instrumented treadmill with visual context presented on the belt’s surface using a projector. The handrail and an emergency stop allow for a safe practice environment (a). The walking adaptability exercises include visually guided stepping to a sequence of regular or irregular stepping targets (b), obstacle avoidance (c), speeding up and slowing down by following a moving walking zone (d) and interactive walking adaptability games (e)
Study assessment schedule
| T0 | T1 | T2 | T3 | ||
|---|---|---|---|---|---|
| Primary outcome measure related to general walking ability | |||||
| Performance Oriented Mobility Assessment (POMA) | Widely used tool for assessing mobility and fall risk in older people. The assessment examines several qualitative aspects of the locomotion pattern and carries the subject through positions and changes in positions, reflecting stability tasks that are related to daily activities. Each item is scored on a 2- or 3-point scale (0–1 or 0-1-2 points), resulting in a maximum score of 28 [ | x | x | x | x |
| Elderly Mobility Scale (EMS) | Covers locomotion, balance and key position changes which are prerequisites to more complex activities of daily living by testing: lying to sitting, sitting to lying, sitting to standing, standing, gait, walking speed and functional reach. The maximum score possible, which represents independent mobility is 20, the minimum score is 0 [ | x | x | x | x |
| Timed Up-and-Go test (TUG) | A measure of functional mobility. The participant is asked to rise from a standard chair, walk to a line on the floor 3 m away, turn, return and sit down again. The score given is the time taken in seconds to complete the test [ | x | x | ||
| Functional Ambulation Category (FAC) | A quick visual measurement of the independence of walking. The FAC distinguishes 6 levels of walking ability based on the amount of human assistance required [ | x | x | x | x |
| 10 m Walking Test (10MWT) | Measures the walking speed over 10 m [ | x | x | ||
| Nottingham Extended Activities of Daily Living (NEADL) | Measures the performance of activities of daily living. The NEADL comprises 22 items divided into four sections: mobility, kitchen, domestic and leisure. Each item is given one of four responses (able 3 pt, able with difficulty 2 pt, able with help 1 pt, unable 0 pt) [ | x | x | x | |
| Primary outcome measures related to walking adaptability | |||||
| 10 m Walking Test with obstacles (10MWTobstacle) | This is a 10 m walk test with 3 obstacles in the walkway to evaluate obstacle avoidance during walking. Two obstacles of 5×20×10 cm [height× width× length] are placed at 2.5 and 7.5 m from the starting line and one obstacle of 10×20×5 cm is placed at 5 m from the starting line. | x | x | ||
| 10 m Walking Test with cognitive task (10MWTcognitive) | This is a 10 m walk test that is performed while participants subtract 3’s from a random number between 191 and 199. This test is performed to evaluate the cognitive dual-task effect of walking. | x | x | ||
| Secondary outcome measure, related to fear of falling | |||||
| Falls Efficacy Scale International (FES-I) | Measures confidence in performing a range of specific activities of daily living without falling. The scale consists of 20 items of which each is responded with one of the following answers: not at all concerned (1 pt), somewhat concerned (2 pt), fairly concerned (3 pt), very concerned (4 pt) [ | x | x | x | x |
| Secondary outcome measure, related to fall incidence | |||||
| Monthly fall diary | Falls and near falls are monitored monthly from T1 to T3 using a daily calendar diary for postal use [ | x | |||
| Secondary outcome measures, related to general health | |||||
| Visual Analogue Scale of perceived general health (VAS) | Participants rate their presently perceived general health using a visual analogue scale (VAS) ranging from 0 (worst imaginable health state) to 100 (best imaginable health state). | x | x | x | x |
| Hip Disability and Osteoarthritis Score - Quality of life (HOOS-Q) | This subscale of the HOOS measures hip-related quality of life and consists of 4 questions. Standardized response options are given (5-point Likert scale) and each of the 4 questions is scored from 0 to 4; then a normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for the subscale [ | x | x | ||
| Trail Making Test – parts A and B (TMTa, TMTb) | The TMT was performed to evaluate executive function, which comprises multiple cognitive processes (i.e., visual scanning, task shifting, planning and mental flexibility). Part A of the TMT consists of 25 circles distributed over an entire page and numbered 1 to 25. The participant is required to connect the circles with a pencil line as quickly as possible, beginning with 1 and proceeding in numerical sequence. Part B consists of 25 circles, numbered 1 to 13 and lettered from A to L. The participant is required to connect the circles, but alternating between numbers and letters and taking both series in ascending sequence. The score for the test was the number of seconds required for completion of each part [ | x | x | x | x |
Fig. 2Flow chart of the study procedures. Abbreviations: AT: adaptability treadmill, CT: conventional treadmill, UPT: usual physical therapy
Participant characteristics
| AT | CT | UPT |
| |
|---|---|---|---|---|
| Demographics | ||||
| Age, years | 82.9 ± 6.5 | 83.9 ± 5.5 | 83.3 ± 8.0 | 0.877a |
| Height, m | 168.6 ± 9.6, | 166.8 ± 10.8, | 166.2 ± 8.3 | 0.691a |
| Body mass, kg | 72.3 ± 14.7, | 71.4 ± 12.7 | 68.7 ± 16.7 | 0.695a |
| Gender, n male (%) | 8 (33.3) | 9 (39.1) | 2 (8.7) |
|
| Medical information | ||||
| Comorbidities |
| |||
| Cardiovascular/respiratory diseases, n (%) | 21 (91.3) | 19 (82.6) | 19 (82.6) | 0.755b |
| Gastrointestinal disorders, n (%) | 2 (8.7) | 4 (17.4) | 5 (21.7) | 0.598b |
| Urogenital disorders, n (%) | 6 (26.1) | 3 (13.0) | 0 (0.0) |
|
| Musculoskeletal disorders, n (%) | 9 (39.1) | 5 (21.7) | 5 (21.7) | 0.353b |
| Neurological disorders, n (%) | 5 (21.7) | 6 (26.1) | 4 (17.4) | 0.933b |
| Psychiatric disorders, n (%) | 1 (4.3) | 2 (8.7) | 3 (13.0) | 0.865b |
| Endocrine disorders, n (%) | 6 (26.1) | 8 (34.8) | 11 (47.8) | 0.346b |
| Other, n (%) | 0 (0.0) | 1 (4.3) | 0 (0.0) | 1.000b |
| Medication use |
| |||
| Vitamine D, n (%) | 6 (26.1) | 5 (21.7) | 9 (39.1) | 0.503b |
| Antidepressants, n (%) | 2 (8.7) | 3 (13.0) | 4 (17.4) | 0.902b |
| Benzodiazepines, n (%) | 3 (13.0) | 3 (13.0) | 3 (13.0) | 1.000b |
| Antihypertensives, n (%) | 17 (73.9) | 15 (65.2) | 16 (69.6) | 0.945b |
| Analgesics: None/Non-opioids/Opioids, n (%) | 1 (4.3)/16 (69.6)/6 (26.1) | 1 (4.3)/15 (65.2)/7 (30.4) | 0 (0.0)/19 (82.6)/4 (17.4) | 0.754c |
| Type of fracture | 0.814b | |||
| Cervical, n (%) | 11 (45.8) | 11 (47.8) | 8 (34.8) | |
| Trochanteric, n (%) | 12 (50.0) | 12 (52.2) | 14 (60.9) | |
| Subtrochanteric, n (%) | 1 (4.2) | 0 (0.0) | 1 (4.3) | |
| Time since fracture, days† | 13 (7–65) | 13 (6–63) | 14 (7–79) | 0.924c |
| Surgery | 0.610b | |||
| None, n (%) | 0 (0.0) | 0 (0.0) | 2 (8.7) | |
| Total hip replacement, n (%) | 1 (4.2) | 0 (0.0) | 1 (4.3) | |
| Hemiarthroplasty, n (%) | 8 (33.3) | 10 (43.5) | 6 (26.1) | |
| Intramedullary nail, n (%) | 11 (45.8) | 10 (43.5) | 9 (39.1) | |
| Dynamic hip screw, n (%) | 4 (16.7) | 2 (8.7) | 5 (21.7) | |
| Other, n (%) | 0 (0.0) | 1 (4.3) | 0 (0.0) | |
| Pre-fracture functioning | ||||
| Functional ambulation category, FAC [0–5]† | 5.0 (4.0–5.0) | 5.0 (4.0–5.0) | 5.0 (2.0–5.0) | 1.000c |
| Living situation, n living independent (%) | 21 (87.5) | 16 (70.0) | 18 (78.3) | 0.312b |
| Ambulatory assistance | ||||
| Indoors, n (%) | 5 (20.8) | 5 (21.7) | 6 (26.1) | 0.939b |
| Outdoors, n (%) | 14 (58.3) | 12 (52.2) | 12 (52.2) | 0.911b |
| Tolerated walking distance, n >1000 m (%) | 8 (33.3) | 9 (39.1) | 14 (60.9) | 0.138 b |
| Baseline functioning | ||||
| Functional Ambulation Category, FAC [0–5]† | 2.0 (2.0–4.0), | 2.0 (2.0–4.0) | 2.0 (2.0–4.0) | 0.200c |
| Performance oriented mobility assessment, POMA [0–28] | 15.6 ± 2.8 | 15.5 ± 3.6 | 15.6 ± 4.1 | 0.994a |
| Mini-Mental State Examination, MMSE [0–30]† | 25.0 (19.0–30.0), | 26.0 (22.0–30.0) | 27.0 (22.0–29.0) | 0.342c |
Abbreviations: AT: adaptability treadmill training group, CT: conventional treadmill training group, UPT: usual physical therapy group
†Reported as median (minimum-maximum)
P values were obtained using
aOne-Way ANOVA
bFisher’s exact test
cKruskal-Wallis test
Significant differences among groups are presented in bold (p < 0.05)
General walking ability
| Outcome (n: AT, CT, UPT) | INTERVENTION | Difference among groups | Mixed RM ANOVA T0, T1, T2 | |||||
|---|---|---|---|---|---|---|---|---|
| AT | CT | UPT |
| Effect size | Time effect | Group effect | Time × Group | |
| POMA (0–28) | ||||||||
| T0 (19, 17, 21) | 15.5 ± 2.9 | 15.6 ± 3.2 | 15.6 ± 4.4 | 0.997a | 0.000 | F (2)=83.423 | F (2)=0.257 | F (3.3)=0.484 |
| T1 (19, 17, 21) | 19.4 ± 2.1 | 19.6 ± 2.0 | 18.6 ± 3.5 | 0.188b | 0.061 | |||
| T2 (17, 17, 17) | 20.2 ± 2.4 | 20.6 ± 3.8 | 19.5 ± 3.7 | 0.444b | 0.034 | |||
| T3 (8, 12, 14) | 22.4 ± 3.8 | 23.6 ± 3.5 | 23.1 ± 3.6 | 0.367b | 0.065 | |||
| EMS (0–20) | ||||||||
| T0 (19, 17, 21) | 11.2 ± 3.7 | 11.1 ± 3.3 | 10.7 ± 3.7 | 0.904a | 0.004 | F (2)=98.133 | F (2)=0.099 | F (2.9)=1.072 |
| T1 (19, 17, 21) | 15.3 ± 2.3 | 16.5 ± 1.5 | 15.2 ± 3.2 | 0.191b | 0.061 | |||
| T2 (17, 17, 17) | 16.2 ± 2.6 | 16.3 ± 2.4 | 16.3 ± 3.5 | 0.912b | 0.004 | |||
| T3 (8, 12, 14) | 17.1 ± 2.9 | 18.1 ± 1.8 | 17.6 ± 2.3 | 0.334b | 0.070 | |||
| TUG (s) | ||||||||
| T1 (19,17,21) | 26.0 (13.5–60.7) | 23.7 (13.6–48.9) | 23.8 (13.3–79.9) | 0.862c | - | Z=−4.134d
| - |
|
| T2 (17,17,17) | 19.9 (11.9–49.3) | 23.6 (10.4–88.9) | 22.2 (10.4–42.2) | 0.871c | - | |||
| FAC (0–5) | ||||||||
| T0 (19, 17, 21) | 2.0 (2.0–4.0) | 2.0 (2.0–4.0) | 2.0 (2.0–4.0) | 0.110c | - |
| - | - |
| ΔT1 (19, 17, 21) | 1.0 (0.0–2.0) | 2.0 (1.0–2.0) | 1.0 (0.0–2.0) |
| - | |||
| ΔT2 (17, 17, 17) | 1.0 (0.0–2.0) | 2.0 (0.0–3.0) | 1.5 (0.0–3.0) |
| - | |||
| ΔT3 (8, 12, 14) | 1.5 (0.0–3.0) | 2.0 (1.0–3.0) | 2.0 (1.0–3.0) | 0.417c | - | |||
| Walking speed (m/s) | ||||||||
| T1 (19,17,21) | 0.65 ± 0.22 | 0.74 ± 0.24 | 0.62 ± 0.20 | 0.219a | 0.055 | F (1)=7.421 | F (2)=0.369 | F (2)=3.053 |
| T2 (17,17,17) | 0.73 ± 0.20 | 0.72 ± 0.26 | 0.72 ± 0.25 | 0.984a | 0.001 | |||
| NEADL (0–66) | ||||||||
| T0 (18, 17, 21) | 44.2 ± 9.7 | 42.5 ± 13.2 | 49.6 ± 10.9 | 0.133a | 0.073 | F (1)=28.180 | F (2)=0.700 | F (2)=2.828 |
| T2 (17, 17, 17) | 32.2 ± 16.4 | 36.9 ± 15.2 | 33.4 ± 18.6 | 0.267b | 0.055 | |||
| T3 (8, 12, 14) | 42.9 ± 11.7 | 42.0 ± 12.1 | 43.4 ± 11.5 | 0.748b | 0.019 | |||
Measures related to mobility, walking and daily functioning in the adaptability treadmill (AT) group, conventional treadmill (CT) group and usual physical therapy (UPT) group at baseline (T0), directly after (T1), four weeks after (T2) and 12 months (T3) after the intervention
P values for group differences were obtained using
aOne-Way ANOVA
bANCOVA with baseline performance as covariate
cKruskal-Wallis test
dThe effect of time was analyzed using Wilcoxon signed rank test and the Time × Group effect using Kruskal-Wallis test over the change score from T1 to T2.
Δ indicates change relative to baseline, which was evaluated over time using a Friedman test
Significant differences among groups are presented in bold (p < 0.05)
Fear of falling and general health
| Outcome (n: AT, CT, UPT) | INTERVENTION | Difference among groups | Mixed RM ANOVA T0, T1, T2 | |||||
|---|---|---|---|---|---|---|---|---|
| AT | CT | UPT | P value | Effect size (ηp 2) | Time effect | Group effect | Time × Group | |
| FES-I (20–80) | ||||||||
| T0 (19,17,21) | 44.68 ± 12.32 | 44.71 ± 13.00 | 46.52 ± 14.78 | 0.885a | 0.005 | F (1.6)=4.001 | F (2)=0.562 | F (3.2)=1.424 |
| T1 (19,17,21) | 44.16 ± 15.86 | 36.24 ± 13.70 | 39.95 ± 15.06 | 0.212b | 0.057 | |||
| T2 (17,17,17) | 41.94 ± 14.29 | 37.94 ± 14.37 | 39.24 ± 17.20 | 0.681b | 0.016 | |||
| T3 (8,12,14) | 31.63 ± 15.73 | 28.58 ± 5.92 | 27.50 ± 6.53 | 0.500b | 0.045 | |||
| VAS (0–100) | ||||||||
| T0 (19,17,21) | 61.89 ± 18.23 | 67.85 ± 18.88 | 60.57 ± 20.94 | 0.491a | 0.026 | F (1.6)=21.945 | F (2)=0.968 | F (3.2)=0.272 |
| T1 (18,17,21) | 80.83 ± 16.02 | 80.62 ± 15.88 | 76.29 ± 16.39 | 0.661b | 0.016 | |||
| T2 (17,17,17) | 80.82 ± 18.40 | 80.94 ± 14.81 | 76.26 ± 16.46 | 0.805b | 0.009 | |||
| T3 (8,12,13) | 78.13 ± 17.31 | 82.88 ± 11.39 | 77.65 ± 12.24 | 0.675b | 0.027 | |||
| HOOS-Q (0–100) | ||||||||
| T2 (17,17,17) | 54.78 ± 30.10 | 57.35 ± 23.41 | 50.37 ± 20.78 | 0.715a | 0.014 | n: 8, 12, 12 | n: 8, 12, 12 | n: 8, 12, 12 |
| T3 (8,12,14) | 76.56 ± 23.80 | 70.31 ± 23.10 | 78.57 ± 19.26 | 0.619a | 0.030 | |||
| TMTa (s) | ||||||||
| T0 (19, 17, 21) | 98.0 (41.0–262.0) | 100.0 (47.2–164.0) | 86.0 (27.0–300.0) | 0.870c | - | F (1.6)=6.38 | F (2)=0.081 | F (3.1)=2.296 |
| T1 (19, 17, 21) | 88.8 ± 42.1 | 83.4 ± 38.2 | 86.3 ± 58.6 | 0.614b | 0.018 | |||
| T2 (16, 17, 17) | 78.8 ± 39.2 | 97.8 ± 71.1 | 74.2 ± 49.3 | 0.117b | 0.089 | |||
| T3 (8, 12, 14) | 56.8 ± 14.9 | 80.9 ± 40.9 | 84.1 ± 40.5 | 0.615b | 0.032 | |||
| TMTb (s) | ||||||||
| T0 (18, 17, 21) | 205.0 (100.0–300.0) | 252.0 (82.6–300.0) | 232.0 (80.0–300.0) | 0.747c | - | F (2)=3.564 | F (2)=0.251 | F (4)=0.266 |
| T1 (18, 17, 21) | 217.4 ± 87.9 | 211.9 ± 78.4 | 200.6 ± 88.0 | 0.479b | 0.028 | |||
| T2 (15, 17, 17) | 198.1 ± 90.0 | 207.0 ± 82.8 | 191.5 ± 96.2 | 0.731b | 0.014 | |||
| T3 (7, 12, 14) | 200.6 ± 78.2 | 202.8 ± 90.7 | 207.3 ± 94.8 | 0.246b | 0.092 | |||
Measures related to fear of falling and general health in the adaptability treadmill (AT) group, conventional treadmill (CT) group and usual physical therapy (UPT) group at baseline (T0), directly after (T1), four weeks after (T2) and 12 months (T3) after the intervention
P values for group differences were obtained using
aOne-Way ANOVA
bANCOVA with baseline performance as covariate
cKruskal-Wallis test
Walking adaptability
| Outcome | INTERVENTION | Difference among groups | Mixed RM ANOVA T0, T1, T2 | |||||
|---|---|---|---|---|---|---|---|---|
| AT | CT | UPT | P value | Effect size (ηp 2) | Time effect | Group effect | Time × Group | |
| Obstacle effect (%) | ||||||||
| T1 (19,17,21) | −18.00 ± 10.96 | −21.06 ± 11.17 | −24.34 ± 14.45 | 0.281a | 0.046 | F (1)=0.907 | F (2)=0.449 | F (2)=0.750 |
| T2 (17,17,17) | −21.48 ± 9.75 | −24.38 ± 12.11 | −21.63 ± 12.87 | 0.717a | 0.014 | |||
| Obstacle success rate (%) | ||||||||
| T1 (19,17,21) | 100.0 (16.7–100.0) | 100.0 (0.0–100.0) | 83.3 (0.0–100.0) | 0.132b | - | Z=−1.744b
| - |
|
| T2 (17,17,17) | 100.0 (33.3–100.0) | 100.0 (16.7–100.0) | 100.0 (33.3–100.0) | 0.754b | - | |||
| DTE- walking speed (%) | ||||||||
| T1 (18,17,21) | −21.48 ± 18.13 | −35.91 ± 18.56 | −31.77 ± 15.52 |
| 0.110 | F (1)=3.115 | F (2)=3.087 | F (2)=2.779 |
| T2 (16,17,17) | −22.85 ± 17.03 | −32.20 ± 17.48 | −19.83 ± 15.65 | 0.091a | 0.097 | |||
| DTE- subtractions (%) | ||||||||
| T1 (17,17,21) | 4.8 (−100.0–208.0) | 0.0 (−62.8–55.6) | −4.8 (−100.0–58.8) | 0.776b | - | Z= −0.413b
| - |
|
| T2 (16,17,17) | −7.3 (−100.0–120.2) | 13.3 (−26.2–77.3) | 9.4 (−100.0–677.9) | 0.244b | - | |||
Measures related to obstacle avoidance performance and dual-task effects (DTE) in the adaptability treadmill (AT) group, conventional treadmill (CT) group and usual physical therapy (UPT) group directly after (T1) and four weeks after (T2) intervention
P values for group differences were obtained using
aOne-Way ANOVA
bKruskal-Wallis test with the effect of time analyzed using Wilcoxon signed rank test and the Time × Group effect using Kruskal-Wallis test over the change score from T1 to T2
Significant differences among groups are presented in bold (p < 0.05)
Falls in the three intervention groups during the 12-month follow-up period
| AT | CT | UPT | |
|---|---|---|---|
| Number of falls | 11 | 11 | 20 |
| Observation time, person-years | 13.51 | 15.14 | 15.49 |
| Fall incidence rate, falls/person-years | 0.81 | 0.77 | 1.29 |
| Number (%) of fallers | 4 (28.6) | 5 (31.3) | 9 (56.3) |
| Incidence rate ratio (95% CI), relative to UPT | 0.63 (0.22–1.76, | 0.59 (0.22–1.64, | |
| Relative risk (95% CI), relative to UPT | 0.51 (0.20–1.29, | 0.56 (0.24–1.29, |
Abbreviations: AT: adaptability treadmill, CT: conventional treadmill, UPT: usual physical therapy, CI: confidence interval
Fig. 3Overview of the significant main intervention effects (p<0.05) observed in the four subgroups. Abbreviations: AT: adaptability treadmill, CT: conventional treadmill, UPT: usual physical therapy, TMTb: trail making test part B